Global Antimicrobial Resistance Innovation Fund (GAMRIF) - Developing a market shaping framework for AMR interventions in developing countries

CHAI (Clinton Health Access Initiative) is a global health organisation committed to saving lives and reducing the burden of disease in low-and middle-income countries. It works with partners to strengthen the capabilities of governments and the private sector to create and sustain high-quality health systems that can succeed independently. Market Shaping with CHAI is a partnership between the UK government and the Clinton Health Access Initiative (CHAI) to support in-country landscaping (Kenya, Malawi, India, Laos, Vietnam) to collect data on the various dimensions of the AMR spectrum, with an aim to inform the identification of any large-scale interventions. The UK government has invested £645K over a 5-month period into CHAI. This is also supported by Cornell University in the United States working in advisory capacity. Projects funded through the Global AMR Innovation Fund (GAMRIF) will primarily benefit people in LMICs, where the burden of drug-resistant infection is greater.